Loomis, Sayles & Company
CMD

Loomis, Sayles & Company’s Cantel Medical Corporation CMD Stock Holding History

Loomis, Sayles & Company’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-44,344
Closed -$4.94M – 941
2018
Q1 		$4.94M Sell
44,344
-792
-2% -$88.8K 0.01% 537
2017
Q4 		$4.64M Sell
45,136
-12,851
-22% -$1.28M 0.01% 528
2017
Q3 		$5.46M Sell
57,987
-1,504
-3% -$119K 0.01% 512
2017
Q2 		$4.63M Buy
59,491
+6,558
+12% +$493K 0.01% 519
2017
Q1 		$4.24M Sell
52,933
-35,961
-40% -$2.86M 0.01% 529
2016
Q4 		$7M Sell
88,894
-1,447
-2% -$112K 0.02% 489
2016
Q3 		$7.04M Sell
90,341
-8,675
-9% -$629K 0.02% 472
2016
Q2 		$6.8M Buy
99,016
+53,116
+116% +$3.66M 0.02% 474
2016
Q1 		$3.27M Sell
45,900
-3,533
-7% -$222K 0.01% 508
2015
Q4 		$3.07M Buy
49,433
+26,596
+116% +$1.62M 0.01% 516
2015
Q3 		$1.29M Buy
22,837
+3,050
+15% +$162K ﹤0.01% 528
2015
Q2 		$1.06M Sell
19,787
-881
-4% -$42.9K ﹤0.01% 566
2015
Q1 		$982K Buy
20,668
+18,460
+836% +$817K ﹤0.01% 592
2014
Q4 		$96K Buy
2,208
+360
+19% +$14.7K ﹤0.01% 669
2014
Q3 		$64K Buy
+1,848
New +$65.3K ﹤0.01% 688

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Loomis, Sayles & Company's CMD Position: Q2 2018 in Review

Loomis, Sayles & Company sold out of Cantel Medical Corporation (CMD) in Q2 2018, closing a stake of 44,344 shares — an estimated $4.94M sold.

Loomis, Sayles & Company first reported a position in CMD in Q3 2014 and held it in 15 quarters. The position peaked at $7.04M in Q3 2016. 292 funds tracked by Wall St. Rank hold CMD as of Q2 2018.

  • Loomis, Sayles & Company reported no remaining Cantel Medical Corporation position as of Q2 2018 after selling out during the quarter.
  • Loomis, Sayles & Company sold 44,344 Cantel Medical Corporation shares in Q2 2018, an estimated $4.94M.
  • Loomis, Sayles & Company first reported a position in Cantel Medical Corporation in Q3 2014 and held it in 15 quarters.
  • Loomis, Sayles & Company's Cantel Medical Corporation position peaked at $7.04M in Q3 2016.
  • 292 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2018.

Based on Loomis, Sayles & Company's 13F filing for Q2 2018, filed 14 Aug 2018.